Almost 60 mantle cell lymphoma (MCL) specialists from around the world gathered in Atlanta, GA for the Lymphoma Research Foundation's (LRF) Sixth Annual Mantle Cell Lymphoma Consortium (MCLC) Scientific Workshop. Attendees heard presentations addressing several key issues including the biology of MCL, prognostic indicators, new molecular targets, chemoimmunotherapy, transplantation and novel therapeutic approaches.
The MCLC was established by the Lymphoma Research Foundation (LRF) in 2005 to accelerate the pace of mantle cell lymphoma research. Attendees to this year's workshop included: LRF MCLC members, including LRF MCL grant recipients as well as other scientific investigators conducting cutting-edge research.
As in the past, this year's meeting provided a unique opportunity for experts to report on their research findings and exchange ideas on how to best improve treatment options for individuals living with MCL. Those in attendance heard 17 oral presentations, viewed 9 poster presentations and participated in 6 roundtable discussions covering areas such as: Clinical Trails for Younger Patients, Epigenetic Studies in MCL and Cell Cycle Targets for MCL.
A Research Report detailing each oral and poster presentation as well as the roundtable discussions is available. To request a copy, please email email@example.com.
About Mantle Cell Lymphoma
Mantle cell lymphoma (MCL) is a B-cell lymphoma that gets its name because mantle cell tumors are composed of cells that come from the "mantle" zone of the lymph node. Frequently, MCL is diagnosed as a stage 4 disease, often present in lymphnodes above and below the diaphragm and in most cases involves the gastrointestinal tract and bone marrow. MCL is a relatively rare disease, constituting only about 6 percent of all NHL cases in the United States (i.e., only about 3,000 cases per year in the U.S.). This lymphoma usually affects men over the age of 60.
About Mantle Cell Lymphoma Consortium
Established by LRF in January 2005, the MCLC is comprised of more than 100 laboratory and clinical scientists from North America and Europe who focus their research on MCL. The MCLC is designed to accelerate the understanding and treatment of MCL by bringing together these lead investigators, funding innovative studies and creating important resources such as the MCL website and cell bank.
About the Lymphoma Research Foundation
The Lymphoma Research Foundation (LRF) is the nation's largest voluntary health organization devoted exclusively to funding lymphoma research and providing patients and healthcare professionals with critical information on the disease. LRF's mission is to eradicate lymphoma and serve those touched by this disease.
As of June 30, 2008, LRF has funded over $37 million in lymphoma-specific research. The Foundation is the world's largest private funder of mantle cell lymphoma research. LRF also provides a comprehensive series of programs and services for patients, survivors and loved ones affected by lymphoma, including our toll-free Lymphoma Helpline and Clinical Trials Information Service, in-person patient education programs, webcasts/teleconferences and support services.
Marion F. Swan | EurekAlert!
Biomedical research continues to develop rapidly - resources to be pooled in MV
17.09.2018 | Leibniz-Institut für Nutzierbiologie (FBN)
Workshop on sensor data management in September
16.08.2018 | Fraunhofer-Institut für Optronik, Systemtechnik und Bildauswertung IOSB
The more objects we make "smart," from watches to entire buildings, the greater the need for these devices to store and retrieve massive amounts of data quickly without consuming too much power.
Millions of new memory cells could be part of a computer chip and provide that speed and energy savings, thanks to the discovery of a previously unobserved...
What if, instead of turning up the thermostat, you could warm up with high-tech, flexible patches sewn into your clothes - while significantly reducing your...
A widely used diabetes medication combined with an antihypertensive drug specifically inhibits tumor growth – this was discovered by researchers from the University of Basel’s Biozentrum two years ago. In a follow-up study, recently published in “Cell Reports”, the scientists report that this drug cocktail induces cancer cell death by switching off their energy supply.
The widely used anti-diabetes drug metformin not only reduces blood sugar but also has an anti-cancer effect. However, the metformin dose commonly used in the...
A research team from the University of Zurich has developed a new drone that can retract its propeller arms in flight and make itself small to fit through narrow gaps and holes. This is particularly useful when searching for victims of natural disasters.
Inspecting a damaged building after an earthquake or during a fire is exactly the kind of job that human rescuers would like drones to do for them. A flying...
Over the last decade, there has been much excitement about the discovery, recognised by the Nobel Prize in Physics only two years ago, that there are two types...
12.12.2018 | Event News
10.12.2018 | Event News
06.12.2018 | Event News
14.12.2018 | Power and Electrical Engineering
14.12.2018 | Physics and Astronomy
14.12.2018 | Physics and Astronomy